Bright Minds Biosciences Inc DRUG

$22.61 -0.50 (-2.16%)

Valuation

Market cap
224,911,000
Revenue TTM
$0
Net income TTM
$-8,740,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
220,500
Avg volume
191,824
Day's range
$21.56 – $24.28
Shares out
9,732,000
Stochastic %K
69%
Beta
-5.11
Analysts
Strong Buy
Price target
$115.71

Price

Company profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmenta...

Show more

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.

Industry
Biotechnology
Sector
Healthcare
Phone
647 865 8622
Website
https://brightmindsbio.com
Address
19 Vestry Street, New York, United States

Latest news

Stocktwits

resistancebreakers Nov 12, 9:30 AM 0 replies
Baazigar123 Nov 11, 5:49 PM
$DRUG JAGX
0 replies
Bristian Nov 9, 8:45 PM
$DRUG $OMH reminds me of $HKD never forgot those letters hopefully this one is like that one
0 replies
TheRealShortSqueezy Nov 9, 8:44 PM
$OMH 3$ to 85$ makes me remember $DRUG A few years ago.
0 replies
GTA_Terminal Nov 9, 11:35 AM
Dark pool check on $DRUG: what traded off the exchanges in the latest session. That came on a day the stock jumped hard, so the question is whether big holders were chasing it or selling into it. Read the full article for the full details: https://globaltradersacademy.com/articles/dark-pool-check-bright-minds-biosciences-drug?utm_source=stocktwits&utm_medium=social
0 replies
cleanair Nov 6, 5:04 PM
$PTN $RYTM $DRUG what caused $PTN to drop so much recently? Gets back to $19 and that's almost a 4 bagger. Gonna do a little for DD and buy next week if all looks promising. Anything anyone can add would be appreciated.
0 replies
SportTrade Nov 6, 2:47 PM
$PTN $RYTM $DRUG HC Wainwright launched research coverage today on PTN with $12 that price ~100% upside. I think that is conservative and room to raise once they get their next gen MC4R lipidated peptide to provide potentially less than weekly doing vs vs current SOC that doses injections daily and just caught a bug for $10BILLION.PTN is the only other Nasdaq listed MC4R platform and i think smart money investors could act similarly to how DRUG rallied went up 50X+ in two weeks that followed the larger comp $2.4bn Longboard acquisition in sympathy… and here we are with potential $10B comp RYTM take out with PTN… sitting at tiny mkt cap - would be a cheap way for big pharma to hedge RYTM competition …and at a minimum assuages my concerns about the funding overhang and tax loss selling in near term. Dare i say… I think the bottom is in!! GLTA
3 replies
like11 Nov 5, 11:01 PM
$LABT anyone remember $DRUG
0 replies